- Entry
- $82.66
- Final
- $59.64 -27.8%
- Target
- —
- Score
- -1.00
While some might think of juicy burgers and crunchy chicken tendies when reading 'discount', it is actually Novo trading at a discount. Since the crazy market overreaction to Novo's latest GLP-1 drug study results, it has become evident, that Novo Nordisk is heavily undervalued. While Novo can do better communicating the results of the REDEFINE trial (press release on 20th of Dec. 2024) and the study design itself (flexible protocol), Novos care for heavy guys and gals is heart melting. …
— ORIGINAL POST ·
NVO Novo Nordisk A/S is trading at a discount.
· r/wallstreetbets
· Feb 5, 2025